Select language:  
1800 620 420
Close menu

Author: Michael Yare

Leukaemia Foundation HSANZ PhD scholarship for Monash researcher

  • Media releases
  • Research
Read more
Illustration of a microscope, test tubes, and clipboard

About the Hovon 150 Trial

The aim of the HOVON 150 trial* is to recruit 968 patients from Europe, Australia and other participating countries.

  • Acute myeloid leukaemia
  • Research
  • Treatments and side-effects
Read more
Illustration of various treatments, pills, medicines

Making personalised care possible

We've launched a new project to understand what people with CLL go through.

  • Chronic lymphocytic leukaemia
  • Support services
Read more
Wayne-Clark-chronic-lymphocytic-leukaemia

Cancer Concierge Pilot: Assessing CLL needs and providing targeted interventions

More than 80 people with CLL signed up for the Leukaemia Foundation’s Cancer Concierge pilot program that ran for six months, is now closed, and is being evaluated.

  • Chronic lymphocytic leukaemia
  • Support services
Read more
Kim Pendelton, a participant in the Cancer Concierge pilot program, with Cancer Concierge Coordinator, Katherine Treble.

Matt travels to the other side of the world for his ‘miracle drug’

Matt travels to the U.S. every 12 weeks for his hairy cell leukaemia treatment.

  • Other blood cancers
  • Treatments and side-effects
Read more
Matt-Hairy-Cell-Leukaemia-variant

Australians unite for Light the NIght

  • Media releases
  • Our supporters
Read more
Illustration of a mobile phone flashing 'News' on the screen

Australians raise the bar for the Leukaemia Foundation’s U.G.L.Y Bartender of the Year

  • Media releases
  • Our supporters
Read more
Illustration of a mobile phone flashing 'News' on the screen

Quest to better understand MDS and find out more effective therapies

When someone with MDS is treated with azacitidine (Vidaza®), it takes six months to find out if they are responding to the drug. Dr Unnikrishnan is working to change that.

  • Myelodysplastic syndromes
  • Research
Read more
Dr Ashwin Unnikrishnan

Merrick from Berwick has “reported for duty” since 2012

For almost eight years, this has been Brian Merrick’s greeting when entering the treatment room in Melbourne for his monthly round of azacitidine (Vidaza®) injections on a clinical trial.

  • Myelodysplastic syndromes
Read more
Brian Merrick

Talking lymphoma with Associate Professor Jake Shortt

Assoc. Prof. Shortt talks about his work in non-Hodgkin lymphoma research.

  • Non-Hodgkin lymphoma
  • Research
Read more
Jake Shortt